TriLink BioTechnologies, part of Maravai LifeSciences

TriLink BioTechnologies, a Maravai LifeSciences company, is a global leader in nucleic acid and mRNA solutions. TriLink delivers unrivaled chemical and biological experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments depend on TriLink to meet their greatest challenges, from delivering the COVID-19 vaccine at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic response plans. For more information, visit trilinkbiotech.com

Mrna,gmp reagents,gmp services,oligo manufacturing,cleancap,plasmid dna,cdmo,rna,ntps,modified nucleotide triphosphates,and capping reagents

Trilink biotechnologies, part of maravai lifesciences operates in the Biotechnology research industry.

Trilink biotechnologies, part of maravai lifesciences's revenue is 11m - 100m

Trilink biotechnologies, part of maravai lifesciences has 201 - 500 employees.